Evidence map›Paper›PMID 31403687›Full record

ArticleJournal of pediatric psychology2019

Allocation of Treatment Responsibility and Adherence to Hydroxyurea Among Adolescents With Sickle Cell Disease.

Susan E Creary, Avani C Modi, Joseph R Stanek, Deena J Chisolm, Sarah H O'Brien, Cara Nwankwo, Lori E Crosby

Abstract read
In one paragraph

Article in Journal of pediatric psychology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Exploring How Children and Young People With Sickle Cell Disease and Their Families Want to be Involved in Research: A Qualitative Study.Health expectations : an international journal of public participation in health care and health policy · 2025
    Observational
  2. Article
  3. The Effects of Race, Ethnicity, and Gender on Predictors of Asthma Medication Adherence among Early High School Students.Children's health care : journal of the Association for the Care of Children's Health · 2024
    Article
  4. Article
  5. Article
  6. The Evolving Pharmacotherapeutic Landscape for the Treatment of Sickle Cell Disease.Mediterranean journal of hematology and infectious diseases · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Susan E CrearyCenter for Innovation in Pediatric Practice, Nationwide Children's Hospital Research Institute, The Ohio State University.
Avani C ModiDivision of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center.
Joseph R StanekDivision of Hematology/Oncology/BMT Nationwide Children's Hospital.
Deena J ChisolmCenter for Innovation in Pediatric Practice, Nationwide Children's Hospital Research Institute, The Ohio State University.
Sarah H O'BrienCenter for Innovation in Pediatric Practice, Nationwide Children's Hospital Research Institute, The Ohio State University.
Cara NwankwoDivision of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center.
Lori E CrosbyDivision of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center.

Funding

A multidimensional strategy to improve hydroxyurea adherence in children with sickle cellK23HL127303 · NHLBI · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI CREARY, SUSAN · 2015 to 2019
$759k
NHLBI NIH HHS K23 HL127303
6 · The paper itself

Abstract

objectiveAdolescents with sickle cell disease (SCD) are at increased risk for complications. Hydroxyurea is a medication that can ameliorate risk but to benefit, adolescents must adhere to treatment. Study aims were to describe how adolescents and their caregivers decided who was responsible for treatment tasks, to describe adolescents' and caregivers' responsibility for these tasks, and to examine if hydroxyurea adherence was associated with younger adolescent age, less discrepancy between adolescents' and caregivers' reports of adolescent responsibility, and higher caregiver involvement.

methodsTwenty-nine dyads completed treatment responsibility measures. A combination of laboratory and electronic prescription data were used to determine hydroxyurea adherence and electronic medical records were used to determine appointment adherence.

resultsFew dyads agreed or planned how to complete treatment tasks. Adolescents shared responsibility with caregivers for medication-taking tasks. Adolescents perceived caregivers and caregivers perceived adolescents were overall responsible for treatment, especially for appointment tasks. Half of adolescents were adherent to hydroxyurea and half were adherent to appointments but medication adherence was not associated with age, discrepancy between adolescents' and caregivers' responses, or caregiver involvement.

conclusionsDespite frequent hydroxyurea and appointment nonadherence, few adolescents and caregivers plan how to manage adolescents' SCD treatment or perceive they are overall responsible. Future studies are needed to determine the factors that influence these perceptions and if increasing adolescent and caregiver treatment planning improves adherence and clinical outcomes.

Indexed as

CaregiversAdolescentAnemia, Sickle CellChildFemaleHumansHydroxyureaMaleMedication AdherenceYoung AdultHydroxyureaadherenceparent-adolescent communicationsickle cell disease

Identifiers

PMID31403687
PMCPMC6823103

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.